BUY VIAGRA NOW!
Blog from:
Welcome to ezetimibe WebLog
BUY ONLINE!
Let's hope Carrie Cox is sitting down! I have questioned Tim Anderson's thinking — on this blog — in the recent past (that link shows Sanford C. Bernstein analyst Anderson expected SEAS would "vindicate" Schering's Vytorin, at least in part). It would seem that he is starting to see the less-sanguine, and more troubling reality — at least as to the Merck side of the Cholesterol Joint Venture — in the July 21 pulled-guidance from Merck. Do go read all of the Reuters report, but here is a rather punchy pull-quote: . . . .[Cutting Mer
CORRESPONDENCE: Analyses of Cancer Data from Three Ezetimibe Trials
To the Editor: The article by Peto et al. (Sept. 25 issue),1 which reports cancer incidence and mortality in three ......
Read the full post from New England Journal of Medicine
via Blogdigger blog search for ezetimibe.
post-marketing analysis of reported adverse events associated with lipid-lowering medication provide no evidence to support the claim that ezetimibe therapy increases the risk for cancer. Public concern was raised after results from the Simvastatin andCLICK HERE!
No comments:
Post a Comment